Press Releases

 
Press Releases
Date Title/Summary View
May 25, 2017 LAWRENCE, Mass., May 25, 2017 /PRNewswire/ -- NxStage Medical, Inc. (Nasdaq: NXTM), a leading medical technology company focused on advancing renal care, today announced that Jeffrey H. Burbank, Chief Executive Officer, plans to participate in the following schedule of investor conferences. Where applicable, a webcast of the event will be made avai...
May 10, 2017 LAWRENCE, Mass., May 10, 2017 /PRNewswire/ -- NxStage Medical, Inc. (NASDAQ: NXTM), a leading medical technology company focused on advancing renal care, today announced that its next generation hemodialysis system has received FDA clearance.  This innovative system consists of new features and capabilities, including a new touchscreen user interfa...
May 9, 2017 LAWRENCE, Mass., May 9, 2017 /PRNewswire/ -- NxStage Medical, Inc. (Nasdaq: NXTM), a leading medical technology company focused on advancing renal care, today reported financial results for the first quarter of 2017, reviewed recent progress on its product pipeline, and updated its outlook for 2017. ...
Apr 6, 2017 LAWRENCE, Mass., April 6, 2017 /PRNewswire/ -- NxStage Medical, Inc. (Nasdaq: NXTM), a leading medical technology company focused on advancing renal care, today announced plans to release its financial results for the first quarter ended March 31, 2017, on Tuesday, May 9, 2017, before the opening of the financial markets. ...
Mar 9, 2017 LAWRENCE, Mass., March 9, 2017 /PRNewswire/ -- NxStage Medical, Inc. (NASDAQ: NXTM), a leading medical technology company focused on advancing renal care, today announced a series of new research results that highlight the potential for on-site hemodialysis with the NxStage® System One™ in skilled nursing facilities to significantly redu...
Mar 2, 2017 LAWRENCE, Mass., March 2, 2017 /PRNewswire/ -- NxStage Medical, Inc. (NASDAQ: NXTM), a leading medical technology company focused on advancing renal care, today announced that its next generation hemodialysis system has received CE Mark approval.  This innovative system consists of new features and capabilities, including a new touchscreen user int...
Feb 28, 2017 LAWRENCE, Mass., Feb. 28, 2017 /PRNewswire/ -- Highlights: Full-Year Revenue Increases to $366 million, up 9% from 2015 Full-Year Home Revenue Increases to $209 million, up over 14% from 2015 Full-Year Operating Income from Products Business More than Doubles to $23 million O...
Feb 16, 2017 LAWRENCE, Mass., Feb. 16, 2017 /PRNewswire/ -- NxStage Medical, Inc. (Nasdaq: NXTM), a leading medical technology company focused on advancing renal care, today announced that Jeffrey H. Burbank, Founder and Chief Executive Officer, plans to participate in the following schedule of investor conferences. Where applicable, a webcast of the event will...
Feb 3, 2017 LAWRENCE, Mass., Feb. 3, 2017 /PRNewswire/ -- NxStage Medical, Inc. (Nasdaq: NXTM), a leading medical technology company focused on advancing renal care, today announced that Allan Collins, M.D., FACP, a recognized worldwide leader in nephrology, has joined NxStage as Chief Medical Officer to help continue to advance NxStage's innovative pipeline a...
Jan 16, 2017 LAWRENCE, Mass., Jan. 16, 2017 /PRNewswire/ -- NxStage Medical, Inc. (Nasdaq: NXTM), a leading medical technology company focused on advancing renal care, today announced plans to release its financial results for the fourth quarter and full year ended December 31, 2016, on Tuesday, February 28, 2017, before the opening of the financial markets. ...
Page:
1
... NextLast
= add release to Briefcase